| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A brief summary of the America Invents Act
|
Braier, Paul A
|
|
2012
|
|
1 |
p. 29-32
|
artikel
|
| 2 |
A comparison of mechanisms for setting generic drug prices in Canada
|
Hollis, Aidan
|
|
2017
|
|
1 |
p. 19-27
|
artikel
|
| 3 |
Advancing pharmaceutical quality oversight during the lifecycle of generic drug products
|
Rosencrance, Susan M
|
|
2015
|
|
1 |
p. 26-33
|
artikel
|
| 4 |
Australia's Pharmaceutical Patent Review: A brief update
|
Condon, Wayne
|
|
2013
|
|
1 |
p. 65-68
|
artikel
|
| 5 |
Braintree v. Breckenridge and the potential danger of stipulation to a claim construction from an earlier case
|
Rein, Frederick H
|
|
2018
|
|
1 |
p. 40-44
|
artikel
|
| 6 |
Braintree v. Novel: When “a patient” excludes one patient
|
Rein, Frederick H
|
|
2017
|
|
1 |
p. 42-46
|
artikel
|
| 7 |
Call for Papers
|
|
|
2017
|
|
1 |
p. 50
|
artikel
|
| 8 |
Combatting counterfeit drugs: Case studies of Cambodia, Vietnam and Thailand
|
Kuanpoth, Jakkrit
|
|
2018
|
|
1 |
p. 4-15
|
artikel
|
| 9 |
Editorial
|
Tempest, Brian
|
|
2017
|
|
1 |
p. 3-4
|
artikel
|
| 10 |
Editorial
|
Tempest, Brian W
|
|
2018
|
|
1 |
p. 3
|
artikel
|
| 11 |
Editorial
|
Tempest, Brian W
|
|
2015
|
|
1 |
p. 3
|
artikel
|
| 12 |
Editorial
|
Tempest, Brian W
|
|
2019
|
|
1 |
p. 3
|
artikel
|
| 13 |
Editorial
|
Tempest, Brian W
|
|
|
|
1 |
p. 3-4
|
artikel
|
| 14 |
Effect of water temperature on a simple suspension method for lansoprazole orally disintegrating tablets
|
Chono, Sumio
|
|
2019
|
|
1 |
p. 4-9
|
artikel
|
| 15 |
EpiPen® Pricing – Evidence of a systemic problem with drug pricing in the USA
|
Costales, Shruti S
|
|
2018
|
|
1 |
p. 29-34
|
artikel
|
| 16 |
EU Case Reports
|
Burdon, Michael
|
|
2012
|
|
1 |
p. 45-50
|
artikel
|
| 17 |
EU Case Reports
|
Burdon, Michael
|
|
2013
|
|
1 |
p. 59-64
|
artikel
|
| 18 |
Exploring the knowledge and attitude of medical and pharmacy students about generic medicine in Lahore, Pakistan
|
Asif, Usama
|
|
2018
|
|
1 |
p. 22-28
|
artikel
|
| 19 |
Factors determining the post-patent entry of generic medicines in Malaysia: A survey of the Malaysian generic pharmaceutical industry
|
Fatokun, Omotayo
|
|
2013
|
|
1 |
p. 22-33
|
artikel
|
| 20 |
Generic substitution policy implementation: A pharmacists' perspective survey
|
Yousefi, Nazila
|
|
2015
|
|
1 |
p. 17-25
|
artikel
|
| 21 |
Impact of an educational program on knowledge and perceptions of physicians towards generic medicines in Kuala Lumpur, Malaysia
|
Kumar, Rohit
|
|
2015
|
|
1 |
p. 4-10
|
artikel
|
| 22 |
In-depth review on ‘innovation and regulatory challenges of the drug delivering medical devices’
|
Drashti, Patel
|
|
2019
|
|
1 |
p. 18-28
|
artikel
|
| 23 |
Indian API industry has the tide turned?
|
Shreyan, ML
|
|
|
|
1 |
p. 27-38
|
artikel
|
| 24 |
2018 in review: Some recent developments in US case law
|
Braier, Paul A
|
|
2019
|
|
1 |
p. 29-33
|
artikel
|
| 25 |
Introduction to the America Invents Act
|
|
|
2012
|
|
1 |
p. 4-4
|
artikel
|
| 26 |
Knowledge and perception differences towards generic medicines consumption among consumers
|
Dzulkipli, Mohd Redhuan
|
|
|
|
1 |
p. 19-26
|
artikel
|
| 27 |
Latest Top 20 Read Articles
|
|
|
2017
|
|
1 |
p. 47-49
|
artikel
|
| 28 |
Latest Top 20 Read Articles
|
|
|
2018
|
|
1 |
p. 48-50
|
artikel
|
| 29 |
Latest Top 20 Read Articles
|
|
|
2019
|
|
1 |
p. 45-46
|
artikel
|
| 30 |
Legal defenses and outcomes in Paragraph IV patent litigation
|
Glass, Gregory
|
|
2013
|
|
1 |
p. 4-13
|
artikel
|
| 31 |
Mexico sets a good precedent for biologics
|
Jorge, M Fabiana
|
|
2012
|
|
1 |
p. 3-3
|
artikel
|
| 32 |
Middle East generics: Challenges & opportunities
|
Tantash, Mazen
|
|
2012
|
|
1 |
p. 13-20
|
artikel
|
| 33 |
“New Federal Trade Secret Legislation—The “Defend Trade Secrets Act””
|
Handelsman, Jeffrey H.
|
|
2017
|
|
1 |
p. 34-36
|
artikel
|
| 34 |
Outcomes of treatment with pyrimine 60 in Thai myasthenia gravis patients
|
Tiamkao, Somsak
|
|
2013
|
|
1 |
p. 34-38
|
artikel
|
| 35 |
Overcoming challenges in market access of generic medicines in the European Union
|
Dylst, Pieter
|
|
2012
|
|
1 |
p. 21-28
|
artikel
|
| 36 |
Pharmaceutical; Trademark; Patents; News
|
Milchior, Richard
|
|
2012
|
|
1 |
p. 33-35
|
artikel
|
| 37 |
Pharmaceutical; Trademark; Patents; News
|
Milchior, Richard
|
|
2017
|
|
1 |
p. 37-41
|
artikel
|
| 38 |
Pharmaceutical; Trademark; Patents; News
|
Milchior, Richard
|
|
2018
|
|
1 |
p. 35-39
|
artikel
|
| 39 |
Pharmaceutical; trademark; patents; news
|
Milchior, Richard
|
|
2015
|
|
1 |
p. 38-42
|
artikel
|
| 40 |
Pharmaceutical; Trademark; Patents; News
|
Milchior, Richard
|
|
2013
|
|
1 |
p. 46-52
|
artikel
|
| 41 |
Pharmaceutical; Trademark; Patents; News
|
Milchior, Richard
|
|
2019
|
|
1 |
p. 34-44
|
artikel
|
| 42 |
Pharmaceutical; trademark; patents; news
|
Milchior, Richard
|
|
|
|
1 |
p. 46-58
|
artikel
|
| 43 |
Physical properties of lansoprazole orally disintegrating tablets
|
Chono, Sumio
|
|
2017
|
|
1 |
p. 5-8
|
artikel
|
| 44 |
Physicians’ loyalty to branded medicines in low-middle-income countries: A structural equation modeling
|
Mehralian, Gholamhossein
|
|
2017
|
|
1 |
p. 9-18
|
artikel
|
| 45 |
Physicochemical qualities and ingestibility of high value-added amlodipine besilate formulations
|
Chono, Sumio
|
|
2017
|
|
1 |
p. 28-33
|
artikel
|
| 46 |
Santarus, Inc. v. Par Pharmaceutical, Inc.: Is there a new written description requirement for negative limitations?
|
Rein, Frederick H
|
|
2013
|
|
1 |
p. 53-58
|
artikel
|
| 47 |
Supreme court to resolve legality of ‘reverse payment’ settlement agreements between brand-name drug manufacturers and generic competitors
|
Browning, Jill M
|
|
2013
|
|
1 |
p. 39-45
|
artikel
|
| 48 |
Technical gaps faced by Chinese generic medicine manufacturers to achieve the standards of WHO medicines Prequalification
|
Huang, Baobin
|
|
2013
|
|
1 |
p. 14-21
|
artikel
|
| 49 |
The America Invents Act: Post-grant review and paragraph IV certifications
|
Rein, Frederick H
|
|
2012
|
|
1 |
p. 5-8
|
artikel
|
| 50 |
The curious case of India’s Bolar provision
|
Rathod, Sandeep K.
|
|
2018
|
|
1 |
p. 16-21
|
artikel
|
| 51 |
The generic medicines market in Germany
|
Bretthauer, Bork
|
|
2012
|
|
1 |
p. 9-12
|
artikel
|
| 52 |
The hidden challenges of pharmaceutical serialisation by Domino Printing Sciences
|
Stobie, Craig
|
|
2015
|
|
1 |
p. 11-16
|
artikel
|
| 53 |
The test data provision of USMCA: A potential to promote or negate the timely access to genetically engineered biologics?
|
Boru, Zeleke T
|
|
|
|
1 |
p. 5-18
|
artikel
|
| 54 |
The trend in patent infringement litigation against generic drugs or biosimilars in Japan
|
Masuda, Sachiko
|
|
2019
|
|
1 |
p. 10-17
|
artikel
|
| 55 |
Trade agreements that raise barriers to entry and hinder innovation: Is that what we are seeking in current trade agreements?
|
Jorge, M Fabiana
|
|
2013
|
|
1 |
p. 3-3
|
artikel
|
| 56 |
Unigene Laboratories, Inc. et al. v. Apotex, Inc. et al.: Reformulating an old drug is not as obvious as one might think
|
Rein, Frederick H
|
|
2012
|
|
1 |
p. 36-44
|
artikel
|
| 57 |
US Legal and Regulatory Update
|
Braier, Paul A
|
|
2015
|
|
1 |
p. 34-37
|
artikel
|
| 58 |
Will President Trump let them get away with murder?
|
Jorge, Maria Fabiana
|
|
2018
|
|
1 |
p. 45-47
|
artikel
|
| 59 |
Winds of change are blowing for diagnostic methods patents
|
Salen, Kenneth H
|
|
|
|
1 |
p. 39-45
|
artikel
|
Tijdschrift beschrijving